Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Honest Company Inc (HNST) vs Nuwellis Inc (NUWE) Price & Performance

Honest Company IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Honest Company Inc vs Nuwellis Inc — how do they compare? Honest Company Inc trades at $3.88 (market cap $426.55M), while Nuwellis Inc trades at $2.84 (market cap $1.09M). The key difference: Honest Company Inc is far larger — about 391.3× Nuwellis Inc's market cap, and Honest Company Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

HNSTNUWE
Market Cap
$426.55M$1.09M
Sector
Consumer StaplesTechnology
52-Week High
$4.95$527.46
52-Week Low
$2.10$2.80
Enterprise Value
$347.95M-$722.58K

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Honest Company Inc

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.

Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Honest Company Inc

The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.

Read more on HNST

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE